Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Myelocytic, Acute, Pediatric”

152 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 152 results

Early research (Phase 1)Study completedNCT00125840
What this trial is testing

Clofarabine in Adult Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsLeukemia, Lymphocytic, Acute, PediatricLeukemia, Lymphocytic, Acute, Adult+3 more
Genzyme, a Sanofi Company
Early research (Phase 1)Study completedNCT01411267
What this trial is testing

AC220 for Children With Relapsed/Refractory ALL or AML

Who this might be right for
Lymphoblastic Leukemia, Acute, ChildhoodMyelogenous Leukemia, Acute, Childhood
Therapeutic Advances in Childhood Leukemia Consortium 24
Early research (Phase 1)Study completedNCT03263936
What this trial is testing

Epigenetic Reprogramming in Relapse/Refractory AML

Who this might be right for
Acute Myelogenous Leukemia
Therapeutic Advances in Childhood Leukemia Consortium 37
Testing effectiveness (Phase 2)Study completedNCT01036009
What this trial is testing

Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies

Who this might be right for
Acute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+7 more
University of California, San Francisco 43
Testing effectiveness (Phase 2)WithdrawnNCT03324243
What this trial is testing

Crenolanib With Fludarabine and Cytarabine in Pediatric Patients With Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory FLT3-mutated AML
Arog Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT01810120
What this trial is testing

Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT

Who this might be right for
Acute Lymphoblastic LeukemiaLeukemia Acute Myeloid - AMLNon-Hodgkin Lymphoma+1 more
Mariella Enoc 30
Not applicableStudy completedNCT01057290
What this trial is testing

Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 75
Testing effectiveness (Phase 2)WithdrawnNCT00943553
What this trial is testing

Study of Epigenetic Priming Using Decitabine With Front Line Induction Chemotherapy Compared With Immediate Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Who this might be right for
Acute Myelogenous Leukemia (AML)
Eisai Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT07437170
What this trial is testing

Selinexor Combined With Induction Chemotherapy for Children With NUP98-positive AML

Who this might be right for
Acute Myeloid LeukemiaPediatric Acute Myeloid LeukemiaNUP98 Fusion-positive Acute Myeloid Leukemia
The Children's Hospital of Zhejiang University School of Medicine 10
Early research (Phase 1)Looking for participantsNCT06177067
What this trial is testing

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Who this might be right for
Refractory Acute Myeloid LeukemiaRelapsed Acute Myeloid LeukemiaAcute Leukemia of Ambiguous Lineage
St. Jude Children's Research Hospital 24
Early research (Phase 1)Ended earlyNCT01066468
What this trial is testing

Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders.

Who this might be right for
Chronic Myeloid Leukemia (CML)Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)Other Glivec/Gleevec Indicated Hematological Disorders (HES, CEL, MDS/ MPN)
Novartis Pharmaceuticals 3
Not applicableActive Not RecruitingNCT05236764
What this trial is testing

Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionMyelodysplastic Syndromes+8 more
Baylor College of Medicine 3
Early research (Phase 1)Study completedNCT00083070
What this trial is testing

Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 16
Early research (Phase 1)Ended earlyNCT03198234
What this trial is testing

Use of T-allo10 in Hematopoietic Stem Cell Transplantation (HSCT) for Blood Disorders

Who this might be right for
AML - Acute Myeloid LeukemiaMDS (Myelodysplastic Syndrome)Mixed Phenotype Acute Leukemia+3 more
Roncarolo, Maria Grazia, MD 5
Testing effectiveness (Phase 2)Ended earlyNCT03860844
What this trial is testing

Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia
Sanofi 67
Early research (Phase 1)Ended earlyNCT01655875
What this trial is testing

AMD3100 for Sensitizing in Allogeneic Blood or Marrow Transplant for Chemotherapy Resistant Pediatric Acute Leukemia

Who this might be right for
Pediatric Acute Myeloblastic Leukemia, RelapsedPediatric Acute Lymphoblastic Leukemia, Relapsed
Emory University 1
Large-scale testing (Phase 3)Looking for participantsNCT05477589
What this trial is testing

Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML

Who this might be right for
Acute Myeloid Leukemia (AML) in RemissionStem Cell Transplantation
Vastra Gotaland Region 170
Not applicableNo Longer AvailableNCT01200017
What this trial is testing

Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myeloid Leukemia+9 more
Christopher Dvorak
Early research (Phase 1)Study completedNCT00079404
What this trial is testing

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia

Who this might be right for
Acute Undifferentiated LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Acute Myeloid Leukemia+2 more
National Cancer Institute (NCI) 36
Early research (Phase 1)Ended earlyNCT00100152
What this trial is testing

A Notch Signalling Pathway Inhibitor for Patients With T-cell Acute Lymphoblastic Leukemia/Lymphoma (ALL)(0752-013)

Who this might be right for
Leukemia, Lymphoblastic, Acute, T-cellMyelogenous LeukemiaChronic Lymphocytic Leukemia+1 more
Merck Sharp & Dohme LLC 50
Load More Results